Pins matching tag:Cancer

Health Minister Stephen Donnelly signs regulations requiring every alcohol container sold in Ireland to warn of liver disease, fatal cancers and drinking in pregnancy and to show grams of alcohol and calories, from 22 May 2026.

On 14 December 2023 Pfizer completed its acquisition of cancer biotech Seagen for US$229 per share in cash, an enterprise value of about US$43 billion, and donated US Bavencio royalties to AACR to address FTC concerns.

Surgeon General Vivek Murthy's advisory names alcohol the third-leading preventable cause of cancer in the US, behind about 100,000 cases and 20,000 deaths a year, and asks Congress to add a cancer warning to the label unchanged since 1988.

On 23 October 2025 the US FDA approved Blenrep with bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma after at least two prior lines of therapy.

Abbott agreed to buy Cologuard maker Exact Sciences for $105 a share in cash, a total equity value of about $21 billion, to enter cancer screening and precision oncology diagnostics.

North Carolina Governor Josh Stein announced that Johnson & Johnson will build a second multibillion-dollar plant in Wilson, a drug product manufacturing facility for cancer and neurology medicines expected to create up to 500 jobs, beside the $2 billion biologics campus it is already building there.

Abbott closed its $105-a-share cash purchase of Cologuard maker Exact Sciences, which became a wholly owned Abbott subsidiary; Exact Sciences shares last traded on Nasdaq on 20 March.

Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.

Cancer, liver-disease and pregnancy warnings become mandatory on every alcohol container sold in Ireland, after the government pushed the start from 22 May 2026 to 3 September 2028 citing economic circumstances.